Literature DB >> 21037346

Transient subluxation of the femoral head after total hip replacement.

B J McGrory1, C P McGrory, L Barbour, B Barbour.   

Abstract

Dislocation is a common and well-studied complication after total hip replacement. However, subluxation, which we define as a clinically recognised episode of incomplete movement of the femoral head outside the acetabulum with spontaneous reduction, has not been studied previously. Out of a total of 2521 hip replacements performed over 12 years by one surgeon, 30 patients experienced subluxations which occurred in 31 arthroplasties. Data were collected prospectively with a minimum follow-up of two years. Subluxation occurred significantly more frequently after revision than after primary hip replacement, and resolved in 19 of 31 cases (61.3%). In six of the 31 hips (19.4%) the patient subsequently dislocated the affected hip, and in six hips (19.4%) intermittent subluxation continued. Four patients had a revision operation for instability, three for recurrent dislocation and one for recurrent subluxation. Clinical and radiological comparisons with a matched group of stable total hips showed no correlation with demographic or radiological parameters. Patients with subluxing hips reported significantly more concern that their hip would dislocate, more often changed their behaviour to prevent instability and had lower postoperative Harris hip scores than patients with stable replacements.

Entities:  

Mesh:

Year:  2010        PMID: 21037346     DOI: 10.1302/0301-620X.92B11.24702

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  2 in total

1.  Anterior subluxation after total hip replacement confirmed by radiographs: report of two cases.

Authors:  Conor P McGrory; Brian J McGrory
Journal:  Adv Orthop       Date:  2011-05-10

2.  Effect of placement of acetabular prosthesis on hip joint function after THA.

Authors:  Guang Fan; Chuan Xiang; Shuaijie Li; Zhenzhong Gao; Xiaohu Liu; Dongdong He; Jian Sun
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.